The role of APOE gene polymorphisms in lung adenocarcinoma susceptibility and lipid profile
2024

APOE Gene Variants and Lung Cancer Risk

Sample size: 600 publication 10 minutes Evidence: high

Author Information

Author(s): Bi Huanhuan, Ren Dunqiang, Wang Ye, Wang Hongmei, Zhang Chunling

Primary Institution: Qingdao University

Hypothesis

The study investigates the relationship between APOE gene polymorphisms and susceptibility to lung adenocarcinoma (LUAD) and its impact on lipid profiles.

Conclusion

Individuals carrying the APOE ϵ2 allele have an increased susceptibility to developing LUAD, accompanied by disrupted lipid metabolism.

Supporting Evidence

  • The APOE ϵ2 allele was significantly more frequent in the LUAD group than in the control group (15.5% vs. 7%).
  • APOE ϵ2/ϵ2 and ϵ2/ϵ3 genotypes increased susceptibility to LUAD by 3.78-fold and 3.22-fold, respectively.
  • Patients with the ϵ2 allele exhibited disrupted lipid metabolism, characterized by reduced HDL, TC, and FFA levels.

Takeaway

This study found that people with a specific gene variant (APOE ϵ2) are more likely to get a type of lung cancer and have problems with their fat levels in the body.

Methodology

The study analyzed a cohort of 600 individuals, including 200 LUAD patients and 400 healthy controls, using Sanger sequencing to identify APOE gene variants and statistical analyses to assess differences in lipid profiles.

Limitations

The study did not measure APOE serum concentrations and lacked subgroup analyses for T, N, and M staging due to data loss.

Participant Demographics

The study included 600 participants, with 200 LUAD patients and 400 healthy controls, matched for age and without relevant medical conditions.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 1.64–8.71

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1522761

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication